Cargando…
SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism
Context: The current clinical guidelines suggest that confirmatory tests for primary aldosteronism (PA) may be excluded in some of patients who have elevated plasma aldosterone concentration (PAC) under plasma renin suppression. However, this has low priority evidence and is under debate in use of s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207644/ http://dx.doi.org/10.1210/jendso/bvaa046.1542 |
_version_ | 1783530653443162112 |
---|---|
author | Umakoshi, Hironobu Sakamoto, Ryuichi Matsuda, Yayoi Yokomoto-Umakoshi, Maki Nagata, Hiromi Fukumoto, Tazuru Ogata, Masatoshi Ogawa, Yoshihiro |
author_facet | Umakoshi, Hironobu Sakamoto, Ryuichi Matsuda, Yayoi Yokomoto-Umakoshi, Maki Nagata, Hiromi Fukumoto, Tazuru Ogata, Masatoshi Ogawa, Yoshihiro |
author_sort | Umakoshi, Hironobu |
collection | PubMed |
description | Context: The current clinical guidelines suggest that confirmatory tests for primary aldosteronism (PA) may be excluded in some of patients who have elevated plasma aldosterone concentration (PAC) under plasma renin suppression. However, this has low priority evidence and is under debate in use of serum potassium. Objective: This study aimed to investigate an appropriate setting for sparing confirmatory tests in PA. Design and Setting: A retrospective cross-sectional study in a single referral center. Participants: This study included 327 patients who had hypertension under plasma renin suppression and underwent captopril challenge test (CCT) between January 2007 and April 2019. CCT results were used to diagnose PA. Main outcome measure: Diagnostic value of PAC and serum potassium in confirmation of PA. Results: Of the studied patients, 252 of 327 (77%) were diagnosed with PA. All 61 patients with PAC >30 ng/dl were diagnosed with PA. In patients with PAC between 20 and 30 ng/dl, 44 of 55 (80%) were diagnosed with PA, while all 26 with PAC between 20 to 30 ng/dl who had spontaneous hypokalemia were diagnosed with PA. Areceiver operator curve analysis showed that the sensitivity of diagnosis of PA is 100% in our patients, when PAC set at > 28.8 ng/dl and showed that the sensitivity of diagnosis of PA is 100% in our patients with spontaneous hypokalemia, who had PAC < 30 ng/dl, when PAC was set at > 19.2 ng/dl. While, the prevalence of PA was higher in patients with hypokalemia, who had PAC between 10 and 20 ng/dl than in those with PAC < 10 ng/dl. Collectively, 100 out of 102 (98%) with hypokalemia, who had PAC > 10 ng/dl were diagnosed as PA. The proportion of unilateral PA determined by adrenal vein sampling (AVS) was higher in patients who had PAC >30 ng/dl or those with spontaneous hypokalemia who had PAC between 20 and 30 ng/dl than those who did not meet the criteria (76% vs. 17%, P<0.001). Conclusion: Confirmatory tests in PA could be spared in patients who have typical features of PA and these patients had a high probability of unilateral PA on AVS. |
format | Online Article Text |
id | pubmed-7207644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72076442020-05-13 SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism Umakoshi, Hironobu Sakamoto, Ryuichi Matsuda, Yayoi Yokomoto-Umakoshi, Maki Nagata, Hiromi Fukumoto, Tazuru Ogata, Masatoshi Ogawa, Yoshihiro J Endocr Soc Cardiovascular Endocrinology Context: The current clinical guidelines suggest that confirmatory tests for primary aldosteronism (PA) may be excluded in some of patients who have elevated plasma aldosterone concentration (PAC) under plasma renin suppression. However, this has low priority evidence and is under debate in use of serum potassium. Objective: This study aimed to investigate an appropriate setting for sparing confirmatory tests in PA. Design and Setting: A retrospective cross-sectional study in a single referral center. Participants: This study included 327 patients who had hypertension under plasma renin suppression and underwent captopril challenge test (CCT) between January 2007 and April 2019. CCT results were used to diagnose PA. Main outcome measure: Diagnostic value of PAC and serum potassium in confirmation of PA. Results: Of the studied patients, 252 of 327 (77%) were diagnosed with PA. All 61 patients with PAC >30 ng/dl were diagnosed with PA. In patients with PAC between 20 and 30 ng/dl, 44 of 55 (80%) were diagnosed with PA, while all 26 with PAC between 20 to 30 ng/dl who had spontaneous hypokalemia were diagnosed with PA. Areceiver operator curve analysis showed that the sensitivity of diagnosis of PA is 100% in our patients, when PAC set at > 28.8 ng/dl and showed that the sensitivity of diagnosis of PA is 100% in our patients with spontaneous hypokalemia, who had PAC < 30 ng/dl, when PAC was set at > 19.2 ng/dl. While, the prevalence of PA was higher in patients with hypokalemia, who had PAC between 10 and 20 ng/dl than in those with PAC < 10 ng/dl. Collectively, 100 out of 102 (98%) with hypokalemia, who had PAC > 10 ng/dl were diagnosed as PA. The proportion of unilateral PA determined by adrenal vein sampling (AVS) was higher in patients who had PAC >30 ng/dl or those with spontaneous hypokalemia who had PAC between 20 and 30 ng/dl than those who did not meet the criteria (76% vs. 17%, P<0.001). Conclusion: Confirmatory tests in PA could be spared in patients who have typical features of PA and these patients had a high probability of unilateral PA on AVS. Oxford University Press 2020-05-08 /pmc/articles/PMC7207644/ http://dx.doi.org/10.1210/jendso/bvaa046.1542 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Cardiovascular Endocrinology Umakoshi, Hironobu Sakamoto, Ryuichi Matsuda, Yayoi Yokomoto-Umakoshi, Maki Nagata, Hiromi Fukumoto, Tazuru Ogata, Masatoshi Ogawa, Yoshihiro SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title | SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title_full | SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title_fullStr | SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title_full_unstemmed | SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title_short | SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism |
title_sort | sat-551 sparing confirmatory tests in primary aldosteronism |
topic | Cardiovascular Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207644/ http://dx.doi.org/10.1210/jendso/bvaa046.1542 |
work_keys_str_mv | AT umakoshihironobu sat551sparingconfirmatorytestsinprimaryaldosteronism AT sakamotoryuichi sat551sparingconfirmatorytestsinprimaryaldosteronism AT matsudayayoi sat551sparingconfirmatorytestsinprimaryaldosteronism AT yokomotoumakoshimaki sat551sparingconfirmatorytestsinprimaryaldosteronism AT nagatahiromi sat551sparingconfirmatorytestsinprimaryaldosteronism AT fukumototazuru sat551sparingconfirmatorytestsinprimaryaldosteronism AT ogatamasatoshi sat551sparingconfirmatorytestsinprimaryaldosteronism AT ogawayoshihiro sat551sparingconfirmatorytestsinprimaryaldosteronism |